2025 ICD-10-CM Diagnosis Code E25.9

by

Adrenogenital disorder, unspecified

  • E25.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2025 edition of ICD-10-CM E25.9 became effective on October 1, 2024.
  • This is the American ICD-10-CM version of E25.9 – other international versions of ICD-10 E25.9 may differ.

Applicable To

  • Adrenogenital syndrome NOS

The following code(s) above E25.9 contain annotation back-references

 that may be applicable to E25.9:

  • E00-E89  Endocrine, nutritional and metabolic diseases
  • E20-E35  Disorders of other endocrine glands
  • E25  Adrenogenital disorders

Approximate Synonyms

  • Adrenogenital disorder
  • Virilized female due to gestational hyperandrogenism
  • Virilized xx, gestational hyperandrogenism

Clinical Information

  • Abnormal sex differentiation or congenital disorders of sex development caused by abnormal levels of steroid hormones expressed by the gonads or the adrenal glands, such as in congenital adrenal hyperplasia and adrenal cortex neoplasms. Due to abnormal steroid biosynthesis, clinical features include virilism in females; feminization in males; or precocious sexual development in children.

ICD-10-CM E25.9 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):

  • 643 Endocrine disorders with mcc
  • 644 Endocrine disorders with cc
  • 645 Endocrine disorders without cc/mcc

Convert E25.9 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change
  • 2025 (effective 10/1/2024): No change

Diagnosis Index entries containing back-references to E25.9:

error: Content is protected !!